Authors
Keisuke Obara, Daiki Kato, Marina Yuguchi, Momoko Tanaka, Kento Yoshioka, Noritaka Nakamichi, Yoshio Tanaka
Published in
Biological & pharmaceutical bulletin. Volume 49. Issue 8. Pages 1298-1301.
Abstract
Platelet-activating factor (PAF) is known to induce smooth muscle contraction; however, its mechanisms in urinary bladder smooth muscle (UBSM) remain unclear. We investigated the involvement of Orai1 in PAF-induced contraction in guinea pig UBSM. PAF (10-6 M)-induced contraction was markedly inhibited by the Orai1 inhibitor Synta66 (10-5 M) and the L-type voltage-dependent Ca2+ channel (VDCC) inhibitor verapamil (10-5 M). Similarly, under Ca2+-free conditions with store depletion induced by cyclopiazonic acid (3 × 10-5 M), Ca2+-induced contraction was suppressed by Synta66 and verapamil. In contrast, Synta66 only partially inhibited contractions induced by acetylcholine (10-5 M) and α,β-methylene ATP (3 × 10-6 M), and it had no effect on high-potassium chloride (80 mM)-induced contraction. Inhibition of Na+/Ca2+ exchanger 1 (NCX1), transient receptor potential canonical (TRPC) 1/4/5 channels, or anoctamin 1 (ANO1) did not significantly affect PAF-induced contraction. These findings suggest that Orai1 contributes to PAF-induced contraction in association with VDCC-dependent mechanisms, whereas NCX1, TRPC1/4/5 channels, and ANO1 play limited roles under these conditions.
PMID:
42649082
Bibliographic data and abstract were imported from PubMed on 27 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0